Oral LD50 in mouse is 2000 mg/kg, and dermal LD50 is 4060 mg/kg in rat and 2000 mg/kg pig. LC50 of hydrogen peroxide vapours in rat is 2000 mg/m at 4 hours MSDS.
Oral ingestion of high dose hydrogen peroxide may cause chest and stomach pain, loss of consciousness, motor disorders, microhemorrhages and moderate leucocytosis in humans. Inhalation of highly concentrated vapours causes extreme irritation of nose and throat L2024.
Hydrogen peroxide has no known carcinogenic potential. It was shown to be mutagenic to bacteria (Salmonella typhimurium) and the fungi, Neurospora crassa and Aspergillis chevallieri, and induced DNA damage in Escheria coli L2024. It also caused sister chromatid exchanges and chromosomal aberrations in mammalian cells in vitro L2024.
Hydrogen peroxide is the simplest peroxide with a chemical formula H2O2. Hydrogen peroxide is an unstable compound in the presence of a base or catalyst, and is typically stored with a stabilizer in a weakly acidic solution. If heated to its boiling point, it may undergo potentially explosive thermal decomposition. Hydrogen peroxide is formed in the body of mammals during reduction of oxygen either directly in a two-electron transfer reaction L2024. As a natural product of metabolism, it readily undergoes decomposition by catalase in normal cells L2024.
Due to its potent and broad-spectrum antimicrobial actions, hydrogen peroxide is used in both liquid and gas form for preservative, disinfection and sterilization applications as an oxidative biocide A32369. It is used in industrial and cosmetic applications as a bleaching agent. Hydrogen peroxide is also considered as a generally recognized as safe compound by the FDA L2024; it is used as an antimicrobial agent in starch and cheese products, and as an oxidizing and reducing agent in products containing dried eggs, dried egg whites, and dried egg yolks.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Alpha-1-proteinase inhibitor | Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Hydrogen peroxide. |
| Menadione | Menadione may increase the thrombogenic activities of Hydrogen peroxide. |
| Tranexamic acid | Tranexamic acid may increase the thrombogenic activities of Hydrogen peroxide. |
| Aminocaproic acid | Aminocaproic acid may increase the thrombogenic activities of Hydrogen peroxide. |
| Aprotinin | Aprotinin may increase the thrombogenic activities of Hydrogen peroxide. |
| Aminomethylbenzoic acid | Hydrogen peroxide may increase the thrombogenic activities of Aminomethylbenzoic acid. |
| Camostat | Hydrogen peroxide may increase the thrombogenic activities of Camostat. |
| Menadione bisulfite | Hydrogen peroxide may increase the thrombogenic activities of Menadione bisulfite. |
| Fibrinogen human | The therapeutic efficacy of Fibrinogen human can be increased when used in combination with Hydrogen peroxide. |
| Tretinoin | The risk or severity of Thrombosis can be increased when Hydrogen peroxide is combined with Tretinoin. |
| Antihemophilic factor, human recombinant | Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor, human recombinant. |
| Coagulation factor VIIa Recombinant Human | Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human. |
| Coagulation Factor IX (Recombinant) | Hydrogen peroxide may increase the thrombogenic activities of Coagulation Factor IX (Recombinant). |
| Calcium | Hydrogen peroxide may increase the thrombogenic activities of Calcium. |
| Pantothenic acid | Hydrogen peroxide may increase the thrombogenic activities of Pantothenic acid. |
| Formic acid | Hydrogen peroxide may increase the thrombogenic activities of Formic acid. |
| Platelet Activating Factor | Hydrogen peroxide may increase the thrombogenic activities of Platelet Activating Factor. |
| Turoctocog alfa | Hydrogen peroxide may increase the thrombogenic activities of Turoctocog alfa. |
| Catridecacog | Hydrogen peroxide may increase the thrombogenic activities of Catridecacog. |
| Antihemophilic factor (recombinant), PEGylated | Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor (recombinant), PEGylated. |
| Prothrombin | Hydrogen peroxide may increase the thrombogenic activities of Prothrombin. |
| Factor IX Complex (Human) | Hydrogen peroxide may increase the thrombogenic activities of Factor IX Complex (Human). |
| Susoctocog alfa | Hydrogen peroxide may increase the thrombogenic activities of Susoctocog alfa. |
| Eftrenonacog alfa | Hydrogen peroxide may increase the thrombogenic activities of Eftrenonacog alfa. |
| Rusalatide acetate | Hydrogen peroxide may increase the thrombogenic activities of Rusalatide acetate. |
| Vatreptacog alfa | Hydrogen peroxide may increase the thrombogenic activities of Vatreptacog alfa. |
| Factor XIII (human) | Hydrogen peroxide may increase the thrombogenic activities of Factor XIII (human). |
| Von Willebrand factor human | Hydrogen peroxide may increase the thrombogenic activities of Von Willebrand factor human. |
| Coagulation factor X human | Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor X human. |
| Coagulation factor VII human | Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor VII human. |
| Anti-inhibitor coagulant complex | Hydrogen peroxide may increase the thrombogenic activities of Anti-inhibitor coagulant complex. |
| Coagulation Factor IX Human | Hydrogen peroxide may increase the thrombogenic activities of Coagulation Factor IX Human. |
| Antihemophilic factor human | Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor human. |
| Kallidinogenase | Hydrogen peroxide may increase the thrombogenic activities of Kallidinogenase. |
| Trenonacog alfa | Hydrogen peroxide may increase the thrombogenic activities of Trenonacog alfa. |
| Albutrepenonacog alfa | Hydrogen peroxide may increase the thrombogenic activities of Albutrepenonacog alfa. |
| Emicizumab | Hydrogen peroxide may increase the thrombogenic activities of Emicizumab. |
| Nonacog beta pegol | Hydrogen peroxide may increase the thrombogenic activities of Nonacog beta pegol. |
| Moroctocog alfa | Hydrogen peroxide may increase the thrombogenic activities of Moroctocog alfa. |
| Beroctocog alfa | Hydrogen peroxide may increase the thrombogenic activities of Beroctocog alfa. |
| Andexanet alfa | Hydrogen peroxide may increase the thrombogenic activities of Andexanet alfa. |
| Calcium cation | Hydrogen peroxide may increase the thrombogenic activities of Calcium cation. |
| Damoctocog alfa pegol | Hydrogen peroxide may increase the thrombogenic activities of Damoctocog alfa pegol. |
| Turoctocog alfa pegol | Hydrogen peroxide may increase the thrombogenic activities of Turoctocog alfa pegol. |
| Acetylcysteine | The therapeutic efficacy of Acetylcysteine can be decreased when used in combination with Hydrogen peroxide. |
| Alteplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Alteplase. |
| Urokinase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Urokinase. |
| Reteplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Reteplase. |
| Anistreplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Anistreplase. |
| Tenecteplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Tenecteplase. |
| Streptokinase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Streptokinase. |
| Lanoteplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Lanoteplase. |
| Amediplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Amediplase. |
| Saruplase | The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Saruplase. |
| Protein S human | Hydrogen peroxide may increase the thrombogenic activities of Protein S human. |
| Rurioctocog alfa pegol | Hydrogen peroxide may increase the thrombogenic activities of Rurioctocog alfa pegol. |
| Etranacogene dezaparvovec | Hydrogen peroxide may increase the thrombogenic activities of Etranacogene dezaparvovec. |